University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Michael Conte, M.D.

Co-director of the Heart and Vascular Center

Dr. Michael Conte, a vascular surgeon, is co-director of the UCSF Heart and Vascular Center and chief of Vascular and Endovascular Surgery. He specializes in diseases of the aorta and its major branches, aneurysms, carotid artery disease and peripheral artery disease (PAD). He also treats diabetic vascular disease and performs complex revascularization to preserve limb function and prevent amputation. Conte led the largest multi-center clinical trial to date, examining leg bypass surgery in patients with severe PAD and is studying angioplasty and bypass surgery failure and approaches to identify patients at risk.

Conte earned a medical degree at Albert Einstein College of Medicine in New York City. He completed a surgical residency at New York Hospital-Cornell Medical Center and vascular surgery training as a John Homan's Fellow at Brigham and Women's Hospital in Boston and Harvard Medical School. He is a member of the Society for Vascular Surgery and Society of University Surgeons. In 2006, he received the Distinguished Achievement Award from the New York Weill Cornell Medical Center Alumni Council. He serves on the editorial boards for Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery and Vascular.

Clinics

Center for Limb Preservation
400 Parnassus Ave., Room A-6110
San Francisco, CA 94143
Phone: (415) 353-2357
Fax: (415) 353-2669

Hours: Monday to Friday
8 a.m. — 5 p.m.

Vascular and Endovascular Surgery
400 Parnassus Ave., Suite A-6110
San Francisco, CA 94143
Phone: (415) 353-2357
Fax: (415) 353-2669

Hours: Monday to Friday
8 a.m. – 5 p.m.

Vascular Laboratories at Parnassus
505 Parnassus Ave., Eighth Floor, Room M-830A
San Francisco, CA 94143
Phone: (415) 353-1286
Fax: (415) 353-8706

Hours: Monday to Friday
9 a.m. – 5:30 p.m.

Conditions & Treatments

More about Michael Conte

Additional Languages

Spanish

Education

Albert Einstein College of Medicine 1986

Residencies

Cornell Medical Center, General Surgery 1993

Fellowships

Brigham and Women's Hospital, Vascular Surgery 1991
Harvard Medical School, Vascular Surgery 1994
Brigham and Women's Hospital, Vascular Surgery 1994

Selected Research and Publications

  1. Conte MS, Goodney PP. Regarding "Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease". J Vasc Surg. 2014 Jul; 60(1):271-2.
  2. Hiramoto JS, Katz R, Weisman S, Conte M. Gender-specific risk factors for peripheral artery disease in a voluntary screening population. J Am Heart Assoc. 2014; 3(2):e000651.
  3. Walker JP, Hiramoto JS, Gasper WJ, Auyang P, Conte MS, Rapp JH, Lovett DH, Owens CD. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease. J Vasc Surg. 2014 Feb 27.
  4. Nosova EV, Yen P, Chong KC, Alley HF, Stock EO, Quinn A, Hellmann J, Conte MS, Owens CD, Spite M, Grenon SM. Short-term physical inactivity impairs vascular function. J Surg Res. 2014 Feb 12.
  5. Owens CD, Gasper WJ, Walker JP, Alley HF, Conte MS, Grenon SM. Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization. J Vasc Surg. 2014 Apr; 59(4):1016-24.
  6. Oresanya L, Makam AN, Belkin M, Moneta GL, Conte MS. Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance. J Vasc Surg. 2014 Apr; 59(4):996-1002.
  7. Jones DW, Schanzer A, Zhao Y, Mackenzie TA, Nolan BW, Conte MS, Goodney PP. Growing impact of restenosis on the surgical treatment of peripheral arterial disease. J Am Heart Assoc. 2013; 2(6):e000345.
  8. Gasper WJ, Jimenez CA, Walker J, Conte MS, Seward K, Owens CD. Adventitial Nab-Rapamycin Injection Reduces Porcine Femoral Artery Luminal Stenosis Induced by Balloon Angioplasty via Inhibition of Medial Proliferation and Adventitial Inflammation. Circ Cardiovasc Interv. 2013 Dec 1; 6(6):701-9.
  9. Mills JL, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI). J Vasc Surg. 2014 Jan; 59(1):220-234.e2.
  10. Grenon SM, Owens CD, Alley H, Chong K, Yen PK, Harris W, Hughes-Fulford M, Conte MS. n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial. Vasc Med. 2013 Oct; 18(5):263-74.
  11. Vartanian SM, Johnston PC, Walker JP, Runge SJ, Eichler CM, Reilly LM, Hiramoto JS, Conte MS. Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease. J Vasc Surg. 2013 Dec; 58(6):1525-31.
  12. Grenon SM, Vittinghoff E, Owens CD, Conte MS, Whooley M, Cohen BE. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study. Vasc Med. 2013 Aug; 18(4):176-84.
  13. Grenon SM, Conte MS, Nosova E, Alley H, Chong K, Harris WS, Vittinghoff E, Owens CD. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease. J Vasc Surg. 2013 Nov; 58(5):1283-90.
  14. Misra S, Lookstein R, Rundback J, Hirsch AT, Hiatt WR, Jaff MR, White CR, Conte M, Geraghty P, Patel M, Rosenfield K. Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia. J Vasc Interv Radiol. 2013 Apr; 24(4):451-8.
  15. Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, Fitzgerald JM, Serhan CN, Conte MS. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J. 2013 Jun; 27(6):2220-32.
  16. McPhee JT, Nguyen LL, Ho KJ, Ozaki CK, Conte MS, Belkin M. Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia. J Vasc Surg. 2013 Jun; 57(6):1481-8.
  17. Conte MS. Critical appraisal of surgical revascularization for critical limb ischemia. J Vasc Surg. 2013 Feb; 57(2 Suppl):8S-13S.
  18. Kraiss LW, Conte MS, Geary RL, Kibbe M, Ozaki CK. Setting high-impact clinical research priorities for the Society for Vascular Surgery. J Vasc Surg. 2013 Feb; 57(2):493-500.
  19. Conte MS, Owens CD, Belkin M, Creager MA, Edwards KL, Gasper WJ, Kenagy RD, LeBoeuf RC, Sobel M, Clowes A. A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts. J Vasc Surg. 2013 May; 57(5):1179-85.e1-2.
  20. Grenon SM, Jeanne M, Aguado-Zuniga J, Conte MS, Hughes-Fulford M. Effects of gravitational mechanical unloading in endothelial cells: association between caveolins, inflammation and adhesion molecules. Sci Rep. 2013; 3:1494.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.